Articles with "biosimilar medicines" as a keyword



Benefits and drawbacks of moving to biosimilar medicines

Sign Up to like & get
recommendations!
Published in 2019 at "Prescriber"

DOI: 10.1002/psb.1773

Abstract: The recent introduction of four biosimilars to the anti‐TNF monoclonal antibody adalimumab has raised the prospect of significant cost savings for the NHS. But what are biosimilar medicines, how easy is it to switch patients… read more here.

Keywords: drawbacks moving; biosimilar medicines; moving biosimilar; benefits drawbacks ... See more keywords

Regulation of biosimilar medicines and current perspectives on interchangeability and policy

Sign Up to like & get
recommendations!
Published in 2018 at "European Journal of Clinical Pharmacology"

DOI: 10.1007/s00228-018-2542-1

Abstract: Competition arising from the increasing availability of biosimilar medicines has resulted in healthcare savings and has provided greater patient access to high cost therapeutics in Europe. The biosimilar market in the USA is relatively new… read more here.

Keywords: policy; regulation biosimilar; interchangeability; medicines current ... See more keywords

Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market

Sign Up to like & get
recommendations!
Published in 2024 at "Expert Opinion on Biological Therapy"

DOI: 10.1080/14712598.2024.2363229

Abstract: ABSTRACT Introduction After 17 years on the market, biosimilar medicines have contributed significantly to the sustainability of healthcare in Spain, providing cost-effective treatment options and savings of more than €1 billion by 2022 alone. To fully… read more here.

Keywords: market; biosimilar medicines; evidence based; overview biosimilar ... See more keywords
Photo from wikipedia

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Oncology Pharmacy Practice"

DOI: 10.1177/1078155220957079

Abstract: Purpose The aim of this study was to assess the safety profiles of two biosimilar medicines (rituximab and trastuzumab) in the treatment of cancer patients within a Portuguese oncology hospital. Methods This hospital-based prospective observational… read more here.

Keywords: rituximab trastuzumab; portuguese oncology; safety; hospital ... See more keywords

Nurses’ Knowledge and Attitudes towards Biosimilar Medicines as Part of Evidence-Based Nursing Practice—International Pilot Study within the Project Biosimilars Nurses Guide Version 2.0

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Environmental Research and Public Health"

DOI: 10.3390/ijerph191610311

Abstract: Introduction: The increasing availability of biosimilars can increase patient access to these drugs and reduce the economic burden. Nurses play a key role in the education, administration, pharmacovigilance and management of the side effects of… read more here.

Keywords: biosimilar medicines; knowledge attitudes; attitudes towards; towards biosimilar ... See more keywords

A Regulatory Perspective on Biosimilar Medicines

Sign Up to like & get
recommendations!
Published in 2024 at "Pharmaceutics"

DOI: 10.3390/pharmaceutics16030321

Abstract: By definition, biosimilar medicinal products are biological medicinal products that are similar to other biological medicinal products that are already on the market—the reference medicinal products. Access to biosimilar medicines is a current reality. However,… read more here.

Keywords: market; biosimilar medicines; perspective biosimilar; medicinal products ... See more keywords

Documento de posicionamiento de la Sociedad Española de Farmacia Hospitalaria sobre los medicamentos biosimilares

Sign Up to like & get
recommendations!
Published in 2018 at "Farmacia Hospitalaria"

DOI: 10.7399/fh.10973

Abstract: Biological medicines nowadays have a great impact, as they offer treatment for  diverse diseases and suppose a high cost for health system. Biosimilar medicines contain a version of an active substance already authorized as an original  biotechnological medicine,… read more here.

Keywords: medicine; documento posicionamiento; farmacia hospitalaria; pharmacy ... See more keywords